For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Niacin, also known as nicotinic acid, is an organic compound and is, depending on the definition used, one of the 20 to 80 essential human nutrients. Together with nicotinamide it makes up the group known as vitamin B3 complex. It has the formula C6H5NO2 and belongs to the group of the pyridinecarboxylic acids.
Scope of the Report:
In global market, the sales of Nicotinamide increased from 55407 MT in 2013 to 76862 MT in 2017. In 2017, the global Nicotinamide market is led by Europe, capturing about 31.97% of global Nicotinamide consumption. China is the second-largest region-wise market with 28.81% global consumption share. The global Nicotinamide (NAA) (aka Niacinamide) market is valued at USD 605.04 million in 2017 and is expected to reach USD 724.10 million by the end of 2024, growing at a CAGR of 2.60% between 2017 and 2024.
At present, the major manufacturers of Nicotinamide are concentrated in Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology, Lasons India, Vanetta, DSM and Tianjin Zhongrui Pharmaceutical. Lonza is the world leader, holding 45.79% consumption market share in 2017. Lonza's main markets are China and Europe. Vertellus is the only producer in the United States. At present, Vertellus Europe's production capacity has been transferred to China. In 2014, Lonza built a new 15,000 production line in China. At the same time, Lonza shut down the oldest production line (5000 tons production line in 1995) due to environmental stress. At present, Lonza has 25,000 tons production capacity in China (10000 tons production line in 2005 and 15,000 tons production line in 2014).
The worldwide market for Nicotinamide (NAA) (aka Niacinamide) is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 680 million US$ in 2024, from 610 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nicotinamide (NAA) (aka Niacinamide) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Lonza
- Jubilant Life Sciences
- Vertellus
- Brother Enterprises
- Zhejiang Lanbo Biotechnology
- Lasons India
- Vanetta
- DSM
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Pharmaceutical Grade
- Feed Grade
- Other
Market Segment by Applications, can be divided into
- Feed Additives
- Food and Drinks Industry
- Pharmaceutical Industry
- Daily Chemicals
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nicotinamide (NAA) (aka Niacinamide) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nicotinamide (NAA) (aka Niacinamide), with price, sales, revenue and global market share of Nicotinamide (NAA) (aka Niacinamide) in 2017 and 2018.
Chapter 3, the Nicotinamide (NAA) (aka Niacinamide) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nicotinamide (NAA) (aka Niacinamide) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nicotinamide (NAA) (aka Niacinamide) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nicotinamide (NAA) (aka Niacinamide) sales channel, distributors, customers, research findings and conclusion, appendix and data source.